The global dermal facial fillers market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing demand for aesthetic procedures and rising awareness about skin care products. Dermal facial fillers are used in various applications such as hospitals and dermatological clinics, beauty centers and medical spas, which are driving the growth of this market.
The global dermal facial fillers market is segmented on the basis of type into Juvéderm XC / Juvéderm Ultra XC / Juvéderm Voluma XC, Restylane Silk / Restylane / RestylanL, Perlane / PerlanL, Sculptra and Radiesse. The application segment includes hospitals and dermatological clinics, beauty centers and medical spas. The regional segmentation includes North America (US, Canada), Latin America (Mexico), Europe (Germany), Asia Pacific (China) Middle East & Africa (Saudi Arabia).
-The global Dermal Facial Fillers market is expected to grow at a CAGR of 6.2% during the forecast period, 2018-2025.
-The global Dermal Facial Fillers market is expected to reach USD 3.5 billion by 2025 from USD 2.4 billion in 2018, growing at a CAGR of 6.2%.
-Increasing demand for aesthetic procedures and rising disposable income are the major factors driving the growth of this market globally.
Industry Growth Insights published a new data on “Dermal Facial Fillers Market”. The research report is titled “Dermal Facial Fillers Market research by Types (Juvéderm XC / Juvéderm Ultra XC / Juvéderm Voluma XC, Restylane Silk / Restylane / Restylane-L, Perlane / Perlane-L, Sculptra, Radiesse), By Applications (Hospitals and dermatological clinics, Beauty centers and medical spas), By Players/Companies ALLERGAN, Anika Therapeutics, Galderma, Merz Pharma, Sinclair Pharma”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Dermal Facial Fillers Market Research Report
By Type
Juvéderm XC / Juvéderm Ultra XC / Juvéderm Voluma XC, Restylane Silk / Restylane / Restylane-L, Perlane / Perlane-L, Sculptra, Radiesse
By Application
Hospitals and dermatological clinics, Beauty centers and medical spas
By Companies
ALLERGAN, Anika Therapeutics, Galderma, Merz Pharma, Sinclair Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global Dermal Facial Fillers Market Report Segments:
The global Dermal Facial Fillers market is segmented on the basis of:
Types
Juvéderm XC / Juvéderm Ultra XC / Juvéderm Voluma XC, Restylane Silk / Restylane / Restylane-L, Perlane / Perlane-L, Sculptra, Radiesse
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals and dermatological clinics, Beauty centers and medical spas
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- ALLERGAN
- Anika Therapeutics
- Galderma
- Merz Pharma
- Sinclair Pharma
Highlights of The Dermal Facial Fillers Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Juvéderm XC / Juvéderm Ultra XC / Juvéderm Voluma XC
- Restylane Silk / Restylane / Restylane-L
- Perlane / Perlane-L
- Sculptra
- Radiesse
- By Application:
- Hospitals and dermatological clinics
- Beauty centers and medical spas
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Dermal Facial Fillers Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Dermal fillers are substances that are injected into the skin to improve its appearance. They can be used to correct wrinkles, age spots, and other facial flaws.
Some of the key players operating in the dermal facial fillers market are ALLERGAN, Anika Therapeutics, Galderma, Merz Pharma, Sinclair Pharma.
The dermal facial fillers market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Dermal Facial Fillers Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Dermal Facial Fillers Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Dermal Facial Fillers Market - Supply Chain
4.5. Global Dermal Facial Fillers Market Forecast
4.5.1. Dermal Facial Fillers Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Dermal Facial Fillers Market Size (000 Units) and Y-o-Y Growth
4.5.3. Dermal Facial Fillers Market Absolute $ Opportunity
5. Global Dermal Facial Fillers Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Dermal Facial Fillers Market Size and Volume Forecast by Type
5.3.1. Juvéderm XC / Juvéderm Ultra XC / Juvéderm Voluma XC
5.3.2. Restylane Silk / Restylane / Restylane-L
5.3.3. Perlane / Perlane-L
5.3.4. Sculptra
5.3.5. Radiesse
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Dermal Facial Fillers Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Dermal Facial Fillers Market Size and Volume Forecast by Application
6.3.1. Hospitals and dermatological clinics
6.3.2. Beauty centers and medical spas
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Dermal Facial Fillers Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Dermal Facial Fillers Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Dermal Facial Fillers Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Dermal Facial Fillers Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Dermal Facial Fillers Demand Share Forecast, 2019-2026
9. North America Dermal Facial Fillers Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Dermal Facial Fillers Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Dermal Facial Fillers Market Size and Volume Forecast by Application
9.4.1. Hospitals and dermatological clinics
9.4.2. Beauty centers and medical spas
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Dermal Facial Fillers Market Size and Volume Forecast by Type
9.7.1. Juvéderm XC / Juvéderm Ultra XC / Juvéderm Voluma XC
9.7.2. Restylane Silk / Restylane / Restylane-L
9.7.3. Perlane / Perlane-L
9.7.4. Sculptra
9.7.5. Radiesse
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Dermal Facial Fillers Demand Share Forecast, 2019-2026
10. Latin America Dermal Facial Fillers Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Dermal Facial Fillers Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Dermal Facial Fillers Market Size and Volume Forecast by Application
10.4.1. Hospitals and dermatological clinics
10.4.2. Beauty centers and medical spas
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Dermal Facial Fillers Market Size and Volume Forecast by Type
10.7.1. Juvéderm XC / Juvéderm Ultra XC / Juvéderm Voluma XC
10.7.2. Restylane Silk / Restylane / Restylane-L
10.7.3. Perlane / Perlane-L
10.7.4. Sculptra
10.7.5. Radiesse
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Dermal Facial Fillers Demand Share Forecast, 2019-2026
11. Europe Dermal Facial Fillers Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Dermal Facial Fillers Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Dermal Facial Fillers Market Size and Volume Forecast by Application
11.4.1. Hospitals and dermatological clinics
11.4.2. Beauty centers and medical spas
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Dermal Facial Fillers Market Size and Volume Forecast by Type
11.7.1. Juvéderm XC / Juvéderm Ultra XC / Juvéderm Voluma XC
11.7.2. Restylane Silk / Restylane / Restylane-L
11.7.3. Perlane / Perlane-L
11.7.4. Sculptra
11.7.5. Radiesse
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Dermal Facial Fillers Demand Share, 2019-2026
12. Asia Pacific Dermal Facial Fillers Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Dermal Facial Fillers Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Dermal Facial Fillers Market Size and Volume Forecast by Application
12.4.1. Hospitals and dermatological clinics
12.4.2. Beauty centers and medical spas
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Dermal Facial Fillers Market Size and Volume Forecast by Type
12.7.1. Juvéderm XC / Juvéderm Ultra XC / Juvéderm Voluma XC
12.7.2. Restylane Silk / Restylane / Restylane-L
12.7.3. Perlane / Perlane-L
12.7.4. Sculptra
12.7.5. Radiesse
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Dermal Facial Fillers Demand Share, 2019-2026
13. Middle East & Africa Dermal Facial Fillers Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Dermal Facial Fillers Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Dermal Facial Fillers Market Size and Volume Forecast by Application
13.4.1. Hospitals and dermatological clinics
13.4.2. Beauty centers and medical spas
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Dermal Facial Fillers Market Size and Volume Forecast by Type
13.7.1. Juvéderm XC / Juvéderm Ultra XC / Juvéderm Voluma XC
13.7.2. Restylane Silk / Restylane / Restylane-L
13.7.3. Perlane / Perlane-L
13.7.4. Sculptra
13.7.5. Radiesse
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Dermal Facial Fillers Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Dermal Facial Fillers Market: Market Share Analysis
14.2. Dermal Facial Fillers Distributors and Customers
14.3. Dermal Facial Fillers Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. ALLERGAN
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Anika Therapeutics
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Galderma
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Merz Pharma
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Sinclair Pharma
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
